RxNorm 352262 NDC Crossover
Aranesp 300 MCG in 1 ML Injection
Related NDC Codes to RxNorm Concept 352262
The following NDC codes crossover to the RxNorm Concept 352262. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
|---|---|---|---|---|---|---|---|
| 55513-002 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
| 55513-003 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
| 55513-004 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
| 55513-005 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
| 55513-006 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
| 55513-021 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
| 55513-023 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
| 55513-025 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
| 55513-027 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
| 55513-028 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
| 55513-032 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
| 55513-057 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
| 55513-098 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
| 55513-110 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE | |
| 55513-111 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Amgen Inc | ACTIVE |